INTRODUCTION
Regular physical exercise contributes to reducing the prevalence of coronary artery disease (CAD). 1 Aerobic exercises are associated with beneficial changes in the profile of circulating lipids and lipoproteins, 2 body weight, 3 blood pressure, 4 insulin sensitivity 5 and coagulation parameters. 6 It has been reported in the literature that the benefits are proportional to the intensity of the exercise, 7 8 which is determined according to the maximum oxygen uptake (VO 2 max) that represents the gold standard in exercise prescription. According to the American College of Sport Medicine, exercise performed at approximately 50-70% of the VO 2 max is classified as moderate exercise, and exercise performed between 70% and 85% of the VO 2 max is considered high-intensity exercise. 9 The practice of moderate exercise training is associated with increased high-density lipoprotein (HDL) and a reduction in lowdensity lipoprotein (LDL), total cholesterol and triacylglycerol (TAG). 7 10 Lipids are considered to be one of the most important fuel sources during moderate-intensity exercise. 11 12 After a session of prolonged and exhaustive exercise, such as observed in a marathon, there are significant changes in lipid profile, particularly the susceptibility of LDL cholesterol (LDL-C) to oxidation. 8 It is accepted that oxidised LDL (oxLDL) is an important risk factor for atherosclerosis. 13 The oxidative hypothesis related to CAD development has been widely discussed, because many atherogenic effects have been attributed to oxidative stress. 7 In spite of the large quantity of free radicals generated in response to increased oxygen consumption, especially during aerobic exercise, the organism is able to activate adequate antioxidant
What are the new findings?
▪ Marathon runners with higher VO 2 max showed reduction of oxLDL levels after a marathon race. ▪ During and soon after the race, the antioxidative mechanisms, represented by TAC, could prevent the elevation of the oxLDL serum levels. ▪ IgM or IgG isotype anti-oxLDL autoantibodies are not involved in the reduction of oxLDL levels observed immediately after a marathon race.
responses to prevent oxidative damage in tissues, especially in moderate intensity. 14 15 However, in exhaustive exercise, the excessive production of free radicals could favour the oxidation of several molecules, 16 including LDL-C, 17 and cause tissue damage if the antioxidant mechanism is insufficient. Furthermore, it is important to emphasise that a marathon training schedule includes running long distances (between 15 to 25 km, which corresponds to a half-marathon), 2-3 times a week. According to Child et al 18 and Briviba et al, 19 athletes come into an oxidative stress state after a half-marathon. So, during the training, the athlete repeatedly induces an elevation on oxidative stress state. Marzatico et al 20 showed that marathon runners had higher levels of malondialdehyde, conjugated dienes and superoxide dismutase, at rest, than did sedentary controls. Thus, presence of oxidative stress state in marathon runners is not an isolated fact, but a chronic feature.
In addition to antioxidant control, autoantibodies that recognise oxidised LDL (anti-oxLDL), which could be detected in plasma from healthy subjects as well, have been associated with the development of atherosclerosis that can trigger a CAD. 21 22 Whereas the IgG subtype anti-oxLDL autoantibody is correlated with the development of atheromatosis, 22 the IgM isotype demonstrates an atheroprotective function. 23 Anti-oxLDL are autoantibodies or natural antibodies, usually defined as immunoglobulins, which are produced in the absence of any exogenous antigenic stimulation, 24 by a subset of lymphocytes known as B1 or B CD5+ cells, which are highly reactive against autoantigens. 25 These antibodies demonstrate several crucial functions not only as the first line of defence against pathogenic microorganisms by binding to a carbon group in the membrane of pathogens and inducing complement activation, but they also play a role in the recognition and removal of senescent cells, cell debris and other self-antigens. 26 In this study, the effect of a marathon race on oxidative stress and the mechanisms of control of this stress were determined in athletes, before and after the race. We evaluated the plasma lipid profile and serum levels of oxLDL, total antioxidant capacity (TAC) and autoantibodies (IgM and IgG) specific to oxLDL in the marathon runners.
MATERIAL AND METHODS

Study subjects
Twenty male recreational marathon runners living in the city of São Paulo were recruited for this study. The volunteers were invited for the study by email invitation sent for different associations or groups of runners. All the volunteers performed a training volume between 80 and 100 km/week with an average of 90-120 min/day, to prepare for the race. All volunteers of this study concluded the XVII International Marathon of São Paulo in 2012. The baseline characteristics and VO 2 max data of the volunteers are shown in table 1. All the individuals were aware of the possible risks involved in the study, and they provided their consent to the study protocol and signed a consent form. The study protocol and consent form were approved by the UNIFESP-EPM Ethics Committee (number 572/2011). The exclusion criteria included the use of lipid-lowering medications, smoking, use of alcohol or drugs, obesity and pathologies including systemic arterial hypertension, liver, renal, metabolic, inflammatory or neoplastic diseases.
Collection of the samples
The blood samples were collected at rest (baseline-24), immediately after the marathon and again 72 h later. Most of the studies that aimed to evaluate the effect of the marathon race on oxidative stress showed results related to periods before a marathon, immediately after the marathon and 24 h later. Despite the fact that the alterations on oxidative stress induced by marathon race usually returns to basal levels 24 h after the race, there is a study showing that the repercussion of the marathon on oxidative stress may persist 24 h after the race. 27 So we evaluated a late period of 72 h after the marathon to study if alterations induced by the marathon persist. Blood draw for all the individuals was made between 8:00 and 9:00 after a period of 12 h of fasting both at rest and 72 h after the marathon. The last training session was performed 24 h before the blood draw at rest. The athletes were oriented to not perform any training between the period immediately after the marathon and 72 h later. Moreover, all the marathon runners were oriented to ingest sufficient quantities of water before (400-500 mL) and during the race to avoid dehydration. The marathon runners ingested the water provided by the marathon organisers during the race according to their necessity. To assess whether the athletes were adequately hydrated during the race, not only did haematocrit percentages before (48.05±0.72) and immediately after (47.74±0.73) not show significance differences, but also, the relative changes in plasma volume, 28 which were estimated as described by Strauss et al 29 on the basis of haematocrit (%) and haemoglobin (g/dL), were not statistically different (table 1) .
Plasma lipids
The plasma total cholesterol (measured using the cholesterol oxidase-phenol-aminophenazone (CHOD-PAP) method) was determined using commercial kits (Kovalente, São Gonçalo, Brazil). The results were analysed using an automated system (Dimension RxL Max Integrated Chemistry System, Siemens Healthcare Diagnostic, Inc, Deerfield, Illinois, USA). The high cholesterol (HDL-C) and TAG concentrations were determined using commercial kits and an automated analysis system (ADVIA 2400 Chemistry System, Siemens Healthcare Diagnostics, Inc, Deerfield, Illinois, USA). The LDL-C was estimated using the Friedewald formula. 30 Measurement of oxLDL-specific IgM and IgG reactivity Serum anti-oxLDL autoantibodies of the IgM and IgG isotypes were measured by ELISA using previously stored samples. OxLDL diluted (7.5 μg/mL) in phosphatebuffered saline (PBS, pH 7.3) was used to coat the 96-well high, binding microtitre plates (Corning Costar, Corning, New York, USA) overnight at 4 o C, as described by Ketelhuth et al. 21 After being washed with PBS, the plates were blocked with 1% gelatin (Sigma, St Louis, Missouri, USA) in PBS for 2 h at room temperature. The plates were washed with PBS, and the serum samples were diluted 1:400 in PBS for the IgM and IgG measurements. After 2 h of incubation at room temperature, the plates were washed with PBS containing 0.05% of Tween 20 (Merck, Germany) (PBS-T), and 100 μL of horseradish peroxidase-conjugated goat antihuman IgM or IgG (Sigma) diluted to 1:1000 in PBS was added to each well and kept for 2 h at room temperature. After washing with PBS-T, 100 μL of substrate (5.5 mg of o-phenylenediamine in 10 mL of citrate-phosphate buffer pH 4.5 plus 10 μL of 30% H 2 O 2 ) was added to the wells, and the plates were kept in the dark for 10 min. The reaction was stopped by adding 50 μL of 4N H 2 SO 4 . Absorbance was read at 492 nm on a microplate reader (Labsystems Multiskan MS Plate Reader). A buffer blank and control (IgM (91.8 mg/dL) and IgG (1400 mg/dL)) were used to compensate for the intraplate variations. The index of reactivity of each sample was calculated as follows: (Sample Optical Density (OD)-Blank OD)/(Control IgG or IgM ODBlank OD).
Measurement of the oxLDL and TAC
The concentration of the oxLDL and TAC in the serum previously at −80°C was determined by ELISA using the oxLDL Indirect Enzyme Immunoassay kit (USCN Life Science, Inc, Wuhan, China). The TAC was based on the Trolox equivalent antioxidant capacity assay, a colorimetric commercial kit (Cayman Chemical Corporation, Ann Arbour, Michigan, USA), in accordance with the manufacturer's instructions. The positive and negative controls were prepared as described by the manufacturer.
Statistical analysis
The participants age, body mass index, lipid profile and VO 2 max are shown as the mean and SD. The data regarding serum levels of autoantibodies (IgM and IgG isotypes) specific to the oxLDL, TAC and oxLDL are shown as the median, with the respective quartiles. The Friedman test and Müller-Dunn post-test were used to determine whether the difference between the baseline results and the results observed immediately after and 72 h after the marathon race were significant. Pearson's correlation analysis was used to identify a correlation between the oxLDL and VO 2 max, the oxLDL and LDL levels, or the oxLDL and TAC levels. The significance level was set to 5% ( p<0.05).
RESULTS
Changes in lipid profile of athletes after a marathon race
Immediately after the marathon race (table 1) , the levels of total cholesterol and HDL-C did not show alterations in relation to the baseline values. The TAG levels were significantly increased, while the LDL-C levels showed a reduction in comparison to the baseline levels. Seventy-two hours after the marathon, levels of HDL-C did not show alterations in relation to the baseline or immediately after the competition, while the values of total cholesterol and LDL-C showed a significant reduction in comparison to the baseline levels, and the TAG levels returned to the baseline values.
Reduced levels of oxLDL and antioxidants after a marathon race Immediately after the race, the serum concentration of oxLDL (A) and TAC (B) showed a significant reduction compared with the baseline levels, as seen in figure 1.
Seventy-two hours after the race, oxLDL (A) and TAC (B) levels returned to the baseline values.
Autoantibody response to oxLDL in marathon runners
Immediately after or 72 h after the marathon, the levels of the IgM ( figure 2A ) and IgG (figure 2B) isotype autoantibodies specific to oxLDL did not change in comparison to the baseline levels.
Higher VO 2 max is correlated with low oxLDL levels after a marathon race Figure 3 shows that no significant correlation was observed in the analysis between the VO 2 max values and oxLDL levels at rest (A). However, immediately after (B) and 72 h after (C) the race, a significant correlation was observed. The athletes with higher VO 2 max values presented lower oxLDL levels before and after the marathon race, whereas the athletes with reduced VO 2 max values showed higher oxLDL levels.
Lower levels of LDL-C 72 h after a marathon race is correlated with high oxLDL levels Figure 4A shows that a positive correlation was observed between the LDL-C and oxLDL levels at rest. This correlation ceased immediately after the marathon ( figure 4B ). Seventy-two hours after the marathon, the positive correlation returned; however, at this time, the statistical significance was higher than that in the baseline values ( figure 4C ).
Higher levels of the serum antioxidant capacity 72 h after a marathon race is correlated with low oxLDL levels In figure 5 , the analysis of the correlation between the oxLDL and the TAC levels showed no correlation at rest (A) or immediately after the marathon (B). However, there was a significant negative correlation 72 h after the race (C). We observed that the athletes with higher oxLDL levels presented lower TAC levels, and the marathon runners with reduced oxLDL levels showed higher TAC levels.
DISCUSSION
In this study, we showed that after a marathon race, the HDL-C levels remain unchanged immediately after the race and 72 h later, although these levels could increase acutely during a session of exhaustive exercise. 31 In a previous report, we showed a similar result, which corroborates our new observation of HDL-C variations during a marathon. 32 In agreement with other studies, we observed a reduction of the LDL-C levels, a common occurrence presenting after exhaustive exercise such as an ultramarathon or bicycle marathon. 28 33 Although the lipid profile remains as one of the most important factors involved in the development of CAD, 34 in recent years, the oxidative hypothesis related to CAD development has received considerable attention among researchers due to the many proatherogenic effects attributed to oxidative stress. 35 Thus, the study of the mechanisms associated with antioxidative activity in serum is very important. Möhlenkamp et al 36 demonstrated that marathon runners present the same index of coronary artery calcification as sedentary individuals, creating a new question for researchers involved in sports. The question presented is related to the fact that marathon runners have elevated VO 2 max levels and the consumption of oxygen during their athletic activity is increased. During training periods and competition, there is increased generation of free radicals, which could favour the oxidation of LDL-C and, as a deleterious consequence, increasing the probability of marathon runners to develop coronary atheromatosis. Although these facts could explain the findings reported by Möhlenkamp et al, 36 according to the literature, until now, it is impossible to affirm it. So, to understand the effect of a marathon race on serum concentration of oxLDL, we analysed the kinetics of the concentration of the LDL-C and oxLDL during the three different occasions. As shown in table 1, the Figure 3 Pearson's correlation analysis between (oxidised) low-density lipoprotein (ox)LDL (expressed in pg/mL) and VO 2 max (expressed in mL/min/ kg) in a group of marathon runners measured at rest (baseline-A), immediately after a marathon (B) and again, 72 h later (C). Significance level: *p<0.05. Figure 4 Pearson's correlation analysis between (oxidised) low-density lipoprotein (ox)LDL (expressed in pg/mL) and LDL cholesterol (mg/dL) in a group of marathon runners measured on three different occasions: at rest (baseline-A), immediately after a marathon (B) and again, 72 h later (C). Significance level: *p<0.05.
LDL-C levels displayed a continuing reduction after the marathon, whereas the oxLDL levels decreased immediately after the marathon and returned to the basal levels 72 h after the race. In relation to the reduction of oxLDL concentration observed immediately after the marathon, we could suppose that this reduction was related to the reduction of plasma LDL-C concentration.
To test this hypothesis, we performed a correlation analysis between the concentration of LDL-C and oxLDL. We observed that there was a positive correlation at rest; however, this effect was lost immediately after the race. Seventy-two hours after the marathon, the positive correlation returned, with greater significance. Taken together, these results showed that the reduction of oxLDL is an event independent of the reduction of LDL-C observed immediately after the marathon race. Furthermore, in relation to the results observed 72 h after the marathon race, we found that whereas the levels of LDL-C are reduced 72 h after the race, these molecules are more oxidised. In agreement with our results, other studies have shown an enhanced depuration of LDL-C in individuals practising physical exercise 37 38 and have demonstrated that exercise, particularly strenuous exercise, could trigger oxidative stress, resulting in an increased accumulation of secondary products of lipid peroxidation, decreased TAC and increased susceptibility of LDL-C to oxidation, in vitro. Elevated oxLDL levels might be associated with previous macrophage activation by oxLDL or a delay in depuration of oxLDL, perhaps because of a lack of increase of the CD36 receptor scavenger. 39 Our novel findings could present interesting information regarding the mechanisms that athletes develop to protect against the harmful effects of oxidative stress. We observe that marathon runners with higher VO 2 max showed reduced oxLDL levels after a marathon race, raising the possibility that LDL oxidation in betterconditioned athletes is reduced. Antioxidant activity is active during a marathon race, except for that of the IgM or IgG isotype anti-oxLDL autoantibodies.
According to the literature, natural IgM (nIgM) isotype autoantibodies specific to oxLDL act as an atheroprotective factor, [40] [41] [42] and it was demonstrated that lower levels of these antibodies are associated with atheromatosis. The importance of nIgM has been highlighted in recent years. Kyaw et al 43 44 showed the action of B1 cells in atheroprotective activity by the production of nIgM. Elphick et al 45 46 demonstrated, in an animal model, that training increases the production of nIgM. We observed that immediately after and up to 72 h after a marathon race, the levels of the IgM isotype anti-oxLDL autoantibodies remain unchanged, in contrast to the effect that would be expected if the autoantibody were acting to block the oxLDL. The levels of the IgG isotype autoantibodies specific to oxLDL did not show differences between the levels before and after the race. This autoantibody is implicated in the development of atheromatosis and, consequently, with CAD. 47 48 Additionally, we observed other mechanisms of oxidative control during and soon after the race. In these periods, the antioxidative mechanisms were relevant to avoid the elevation of the serum oxidant levels. Immediately after the marathon, the levels of oxLDL and TAC showed a significant decrease compared with the baseline levels. Some studies have demonstrated that oxLDL levels after a marathon could remain unchanged 49 or significantly decrease, 50 as observed in this study. This finding suggests that the antioxidant molecules represented by TAC could buffer oxidative stress, preventing an increase of the oxLDL. Seventy-two hours after the race, the levels of oxLDL and TAC showed a tendency to return to the basal values. Figure 5 Pearson's correlation analysis between (oxidised) low-density lipoprotein (ox)LDL (expressed in pg/mL) and total antioxidant capacity (-mmol/L) in a group of marathon runners measured at rest (baseline-A), immediately after a marathon (B) and again, 72 h later (C). Significance level: *p<0.05.
Further studies evaluating a greater number of participants and the study of endothelia in athletes and sedentary individuals are necessary to definitively confirm the importance of this mechanism as a protective factor against the rise of oxidative stress and development of CAD in athletes who perform a session of exhaustive exercise, such as running a marathon race. Failure of these mechanisms, most likely acting in conjunction with other factors such as genetic propensity, could induce CAD in athletes.
